Rigorous surveillance of children at high risk for developing myelodysplastic syndrome (MDS) is especially warranted, ...

The approval follows a heightened regulatory focus on CAR-T cell therapy safety this year. In April, the FDA mandated boxed ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

The bottom line is that the key to better cancer outcomes is found in early detection. Most malignancies that usually affect ...

While Monday’s trading session was a win for CERo shareholders, the stock’s year-to-date (YTD) performance paints a more complex picture. As of today, CERO is down by a staggering -98.59% YTD, which ...

In an interview, Colton Ladbury, MD, discussed new insights from a study and expanded on total marrow irradiation’s potential ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class ...

Underscoring how trials can benefit all members of a community and discussing spirituality may improve enrollment of Black ...

Patients with HIV infection are at an increased risk of a number of malignancies, including Kaposi's sarcoma (KS) and certain B-cell lymphomas. Most of these tumors are caused by oncogenic DNA ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic signatures.